Evidence map›Paper›PMID 34550549›Full record

ArticleMolecular biotechnology2022

Silencing of Long Non-coding RNA LINC01106 Represses Malignant Behaviors of Gastric Cancer Cells by Targeting miR-34a-5p/MYCN Axis.

Sen Hong, Qiuxia Li, Ying Yang, Deqian Jing, Fengbo Zhu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sen Hong *Digestive System Department, The Fifth People's Hospital of Jinan, No. 24297, Jingshi Road, Jinan City, 250022, Shandong Province, China.
Qiuxia Li *Digestive System Department, The Fifth People's Hospital of Jinan, No. 24297, Jingshi Road, Jinan City, 250022, Shandong Province, China.
Ying YangHyperbaric Chamber, The Fifth People's Hospital of Jinan, Jinan City, 250022, Shandong Province, China.
Deqian JingCommunity Development Department, First People's Hospital of Jinan, Jinan City, 250014, Shandong Province, China.
Fengbo ZhuDigestive System Department, The Fifth People's Hospital of Jinan, No. 24297, Jingshi Road, Jinan City, 250022, Shandong Province, China. zhufengbo252@163.com.ORCID http://orcid.org/0000-0001-9516-323X
Fourth People’s Hospital of Jinan · CNJinan City People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long non-coding RNA LINC01106 is an lncRNA aberrantly expressed in gastric cancer (GC). However, the accurate function remains unclear. The objective of this investigation is to explore detailed regulatory mechanism of lncRNA LINC01106 in GC. The expression of lncRNA LINC01106, MYCN, and miR-34a-5p was determined by quantitative real-time polymerase chain reaction (qRT-PCR). Cell viability was examined using MTT assay. Migratory and invasive abilities of GC cells were evaluated by transwell assay. The targeting relation among lncRNA LINC01106, MYCN, and miR-34a-5p was tested by dual-luciferase reporter (DLR) assay. Relative protein expression of MYCN was assessed via western blot. Besides, a xenograft mouse model was established to assess the role of LINC01106 in GC in vivo. LncRNA LINC01106 and MYCN expression were boosted and miR-34a-5p expression was reduced in GC cells and tissues compared to their controls. Functionally, decreased lncRNA LINC01106 or increased miR-34a-5p restrained GC cells in viability, invasion, and migration in vitro. LINC01106 down-regulation suppressed tumor growth of mice in vivo. In terms of mechanism, lncRNA LINC01106 directly targeted miR-34a-5p and was inversely correlated with miR-34a-5p. MYCN was targeted by miR-34a-5p and was inversely correlated with miR-34a-5p. There was a positive correlation between LINC01106 and MYCN. LINC01106 knockdown led to the suppression of cell invasion, migration, and viability, whereas these effects caused by LINC01106 knockdown were reversed by miR-34a-5p down-regulation or MYCN up-regulation in GC cells. Silencing of lncRNA LINC01106 attenuated cell viability, invasion, and migration by sponging miR-34a-5p to target MYCN in GC.

Indexed as

AnimalsCell Line, TumorCell MovementCell SurvivalFemaleGene Expression Regulation, NeoplasticGene SilencingHumansMaleMiceMice, Inbred BALB CMicroRNAsMiddle AgedN-Myc Proto-Oncogene ProteinRNA, Long NoncodingStomach NeoplasmsMicroRNAsMIRN34 microRNA, humanMYCN protein, humanN-Myc Proto-Oncogene ProteinRNA, Long NoncodingGastric cancerLINC01106Long non-coding RNAmiR-34a-5pMYCN

Identifiers

PMID34550549
OpenAlexW3201001899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.